Target intelligence / Profile preview

Extracellular matrix components and cell-surface adhesion machinery (ECM/CAM)

Target
ECM/CAM
Molecular classification
Structural protein, Glycoprotein, Proteoglycan, Cell adhesion molecule, Receptor, Other
01

Overview

The extracellular matrix (ECM) and cell-surface adhesion machinery represent a vast network of extracellular macromolecules and transmembrane receptors that provide structural scaffolding and biochemical signaling cues to tissues (NCBI, PMC7071957). Major components include fibrous proteins like collagen, glycoproteins such as laminin and fibronectin, and adhesion receptors like integrins, cadherins, and selectins (UniProt; StatPearls, NBK541077). These systems are fundamental for maintaining tissue architecture, facilitating cell migration, and regulating differentiation (PubMed, 29481550). In disease, the remodeling of the ECM and alterations in adhesion molecule expression are hallmarks of cancer metastasis, chronic fibrosis, and inflammatory disorders (Nature Reviews Molecular Cell Biology, 2014). Therapeutic interventions targeting this machinery, such as integrin antagonists, are used to treat conditions ranging from multiple sclerosis to acute coronary syndromes (FDA, Tysabri Label; PubMed, 12750655).

Other names
Extracellular matrixECMCell adhesion moleculesCAMsMatrisomeAdhesion machinery
02

Mechanism of action

Antagonism of cell-surface adhesion receptors (e.g., integrins) to block leukocyte trafficking or platelet aggregation, and enzymatic modulation of the extracellular matrix to alter tissue permeability (NCBI, NBK541077; PubMed, 12750655).

03

Biological functions

Structural supportCell signalingCell adhesionCell migrationTissue morphogenesisWound healingMechanotransduction
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseAutoimmune diseaseGenetic connective tissue disorders
05

Safety considerations

Increased risk of opportunistic infections (e.g., PML)Bleeding and hemorrhageImpaired wound healingInfusion-related reactions
06

Interacting drugs

Natalizumab

7 more in the full profile.

07

Biomarkers

Matrix metalloproteinases (MMPs)Collagen degradation products (e.g., CTX-I, Pro-C3)Soluble ICAM-1Soluble VCAM-1Fibronectin

Beyond the preview

Go deeper on Extracellular matrix components and cell-surface adhesion machinery (ECM/CAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix components and cell-surface adhesion machinery (ECM/CAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call